The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients

Metabolism: Clinical and Experimental

Volumn 49, Issue 7, 2000, Pages 868-872

  Djemli Shipkolye, A ^a,b,c   Gallice, P ^a,b   Coste, T ^a,b   Jannot, M F ^a,b   Tsimaratos, M ^a,b   Raccah, D ^a,b   Vague, P ^a,b  

^a TIMONE HOSPITAL   (France)

^b School of Pharmacy   (France)

^c Lab de Diabetologie Hop de la T   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PHOSPHATE;

ADULT; ARTICLE; CELL SUSPENSION; CLINICAL ARTICLE; DRUG SPECIFICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HYDROLYSIS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; MICROCALORIMETRY; PRIORITY JOURNAL;

EID: 0034235553     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2000.6753     Document Type: Article

References (49)

1. 1. Jorgensen PL: Sodium and potassium ion pump in kidney tubules. Physiol Rev 60:864-917, 1980
2. 2. Greene DA, Lattimer SA, Sima AAF: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-605, 1987
3. 3. Raccah D, Jannot MF, Issautier D, et al: Effect of experimental diabetes on Na/K ATPase activity in red blood cells, peripheral nerve and kidney. Diabete Metab 20:271-274, 1994
4. + ATPase activity in type I (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetes 36:991-995, 1987
5. + ATPase activity in the pathogenesis of human diabetic neuropathy. J Neurol Sci 120:159-167, 1993
6. 6. Raccah D, Fabreguettes C, Azulay JP, et al: Erythrocyte Na/K ATPase activity, metabolic control and neuropathy in insulin dependent diabetic patients. Diabetes Care 19:564-568, 1996
7. 7. Raccah D, Gallice P, Pouget J, et al: Hypothesis: Low Na/K ATPase activities of the red cell membrane, a potential marker of the predisposition to diabetic neuropathy. Diabete Metab 18:236-241, 1992
8. 8. Vague P, Dufayet D, Coste T, et al: Association of diabetic neuropathy with Na/K ATPase gene polymorphism. Diabetologia 40:506-511, 1997
9. 9. Gerbi A, Maixent JM, Barbey O, et al: Alteration of Na/K ATPase isoenzymes in the rat diabetic neuropathy: Protective effect of dietary supplementation with n-3 fatty acids. J Neurochem 71:732-740, 1998
10. 10. Gerbi A, Maixent JM, Ansaldi JL, et al: Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rat. J Nutr 129:207-213, 1999
11. +) ATPase from 3T3-F442A fibroblasts and adipocytes: Isozymes and insulin sensitivity. J Biol Chem 265:10458-10465, 1990
12. + ATPase in isolated rat soleus muscle. Am J Physiol 261:C226-C230, 1991
13. + ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 267:5040-5043, 1992
14. + ATPase α2 subunit in the surface of rat skeletal muscle: Morphological evidence. Am J Physiol 269:C1716-C1722, 1993
15. 15. Klahr S, Sinha S, Yates J: Effects of insulin on sodium transport by the urinary bladder. Ann NY Acad Sci 372:235-246, 1981
16. 16. Shoen HF, Erlij D: Insulin action on electrophysiological properties and apical and basolateral membranes of frog skin. Am J Physiol 252:C411-C417, 1987
17. 17. Matsuda T, Murata Y, Kawamura N, et al: Selective induction of α1 isoform of (Na-K) ATPase by insulin/insulin-like growth factor-1 in cultured rat astrocytes. Arch Biochem Biophys 307:175-182, 1993
18. 18. Gelheter TD, Shreve PD, Dilworth UM: Insulin regulation of Na/K pump activity in rat hepatoma cells. Diabetes 33:428-434, 1984
19. 19. Brodsky JL: Insulin activation of brain Na-K ATPase is mediated by α2-form of enzyme. Am J Physiol 258:C812-C817, 1990
20. 20. Agarwal VR, Rastogi AK, Sahib MK, et al: In vitro insulin action on different ATPases of erythrocyte membranes in normal and diabetic rat. Acta Diabetol Lat 22:111-118, 1985
21. 21. Rahmani-Jourdheuil D, Mourayre Y, Vague P, et al: In vivo insulin effect on ATPase activities in erythrocyte membranes from insulin-dependent diabetics. Diabetes 36:991-995, 1987
22. 22. Rubenstein AH, Clark JL, Melani F, et al: Secretion of proinsulin C-peptide by pancreatic beta cells and its circulation in blood. Nature 224:697-699, 1969
23. 23. Steiner DF: On the role of proinsulin C-peptide. Diabetes 27:145-148, 1978 (suppl)
24. 24. Johansson BL, Sjöberg S, Wahren J: The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35:121-128, 1992
25. 25. Johansson BL, Linde B, Wahren J: Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients. Diabetologia 35:1151-1158, 1992
26. 26. Johansson BL, Borg K, Fernqvist-Forbes E, et al: C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 39:687-695, 1996
27. + ATPase activity in synergism with neuropeptide Y. Diabetologia 39:199-205, 1996
28. 28. Beutler E, West C, Blume KG: The removal of leucocytes and platelets from whole blood. J Lab Clin Med 88:328-333, 1976
29. 29. Issautier T, Kovacic H, Gallice P, et al: Modulation defect of sodium pump evidence in diabetic patients by a microcalorimetric study. Clin Chim Acta 228:161-170, 1994
30. 30. Johansson BL, Kernell A, Sjöberg S, et al: Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 77:976-981, 1993
31. 31. Kunt T, Schneider S, Pfützner A, et al: The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus. Diabetologia 42:465-471, 1999
32. + ATPase activity in type I (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetes 36:991-995, 1986
33. + ATPase activity in diabetes type 1. Diabetologia 42:A201, 1999 (suppl 1, abstr)
34. + transport in diabetes mellitus. Diabetes 39:850-854, 1990
35. + and calmodulin. J Clin Invest 82:394-400, 1988
36. 36. Schischmanoff PO, Winardi R, Disher DE, et al: Defining of the minimal domain of protein 4.1 involved in spectrin-actin binding. J Biol Chem 270:21243-21250, 1995
37. 37. Dufayet De La Tour D, Raccah D, Jannot MF, et al: Erythrocyte Na/K ATPase activity and diabetes: Relationship with C-peptide level. Diabetologia 41:1080-1084, 1998
38. 38. Steiner D, Rubenstein A: Proinsulin C-peptide - Biological activity? Science 277:531-532, 1997
39. 39. Henriksson M, Johansson J, Shafkat J, et al: Proinsulin C-peptide does not bind to lipid vesicles. Diabetologia 42:A200, 1999 (suppl 1, abstr)
40. 40. Flatt PR, Swanston-Flatt SK, Hampton SM, et al: Specific binding of C-peptide of proinsulin to cultured β-cells from a transplantable rat islet cell tumor. Biosci Rep 6:193-199, 1986
41. 41. Forst T, Kunt T, Pohlman T, et al: Proinsulin C-peptide increases plasma c-GMP levels and the endothelium-dependent microvascular response in type 1 diabetic patients. Diabetes 48:A201, 1999 (suppl 1, abstr)
42. 42. Ekberg K, Rigler R, Pramanik A, et al: Specific binding of proinsulin C-peptide to human cell membranes. Diabetologia 42:A200, 1999 (suppl 1, abstr)
43. 43. Stephen Ewart H, Klip A: Hormonal regulation of the Na-K ATPase: Mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 269:C295-C311, 1995
44. 44. Santini MT, Indovina PL, Simmons JR, et al: Human erythrocyte insulin receptor down-regulation is accompanied by a transient decrease in membrane order. Biochim Biophys Acta 1054:333-336, 1990
45. 45. Juhan-Vague I, Rahmani-Jourdeuil D, Mishal Z, et al: Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from type 1 (insulin-dependent) diabetic patients. Diabetologia 29:417-420, 1986
46. 46. Baldini P, Incerpi S, Pascale E, et al: Insulin effects of human red blood cells. Mol Cell Endocrinol 46:93-102, 1986
47. 47. Sjöberg S, Gunnarson R, Gjötterberg M, et al: Residual insulin production and prevalence of microvascular lesions and polyneuropathy in long term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:208-213, 1987
48. 48. Kernell A, Ludvigsson J, Finnström K: Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: Insulin antibodies and C-peptide levels. Acta Ophthalmol Scand 68:415-420, 1990
49. 49. Maffi P, Furiani S, Castelnuovo A, et al: Relationship between C-peptide levels and diabetic neuropathy in type 1 diabetic patients after islet transplantation. Diabetes 48:A55, 1999 (suppl 1, abstr)